15
37 BAB IV KESIMPULAN DAN SARAN A. Kesimpulan Ekstrak Etanolik Biji Sirsak memperlihatkan adanya penghambatan siklus sel kanker payudara T47D di fase G1 dan fase G2/M. Besarnya persentase akumulasi sel pada fase G1 dan G2/M ini sedikit lebih tinggi bila dibandingkan dengan sel tanpa perlakuan (kontrol sel). B. Saran Perlu dilakukan penelitian lebih lanjut yaitu fraksinasi ekstrak etanolik biji sirsak terhadap sel kanker payudara T47D.

BAB IV KESIMPULAN DAN SARAN A. Kesimpulan B. Saraneprints.unwahas.ac.id/1517/5/BAB IV.pdf37 BAB IV KESIMPULAN DAN SARAN A. Kesimpulan Ekstrak Etanolik Biji Sirsak memperlihatkan adanya

Embed Size (px)

Citation preview

37

BAB IV

KESIMPULAN DAN SARAN

A. Kesimpulan

Ekstrak Etanolik Biji Sirsak memperlihatkan adanya penghambatan

siklus sel kanker payudara T47D di fase G1 dan fase G2/M. Besarnya persentase

akumulasi sel pada fase G1 dan G2/M ini sedikit lebih tinggi bila dibandingkan

dengan sel tanpa perlakuan (kontrol sel).

B. Saran

Perlu dilakukan penelitian lebih lanjut yaitu fraksinasi ekstrak etanolik

biji sirsak terhadap sel kanker payudara T47D.

38

DAFTAR PUSTAKA

Alali FQ, Liu XX, McLaughlin JL, 1999. Annonaceous acetogenins: recent

progress. Journal of Natural Product. Vol 62(3), pp. 504-40

Arifianti, L. Sukardiman, Herra. S. Rakhmawati dan Lulus, M., 2014, Uji

Aktivitas Ekstrak Biji Sirsak (Annona muricata L.) Terhadap Sel Kanker

Mamalia Secara In Vitro.

Ayers, L., Kohler, M., Harrison, P., Sargent, I., Dragovic, R., and Schaap, M.,

2011, Measurement of Circulating Cell-derived Microparticles by

Flowcytometry : Source of Variability within the Assay, Thrombosis

Research, 127 : 370-377.

Bishayee, A., Shamima, A., Nikoleta, B., and Marjorie, P., 2011. Triterpenoids as

Potential Agents for the Chemoprevention and Therapy of Breast

Cancer. Front Bioscience, 16, 980–996.

Bruton, L., Lazo, J.S., and Parker, K.L., 2005, Goodman and Gilman;s The

Pharmacilogical Basic of Theurapetics, 11 th edition, McGraw Hill,

Lange

Burdall, E.S., Hanby M.A., Landsdown, R.J.M., and Speirs, V., 2003, Breast

Cancer Cell Line, Breast Cancer Res., 5(2): 89-95

CCRC (Cancer Chemoprevention Research Center), 2009, Panen Sel,

http://ccrc.farmasi.ac.id, diakses tanggal 26 Juli 2017.

CCRC (Cancer Chemoprevention Research Center), 2013, Uji Sitotoksik Metode

MTT, http://ccrc.farmasi.ac.id, diakses tanggal 12 Desember 2017.

CCRC (Cancer Chemoprevention Research Center), 2014, Preparasi Sampel

untuk Siklus Sel dengan metode Flowcytometri, http://ccrc.farmasi.ac.id,

diakses tanggal 12 Desember 2017.

Cordon, C., 2006, p53 and RB: Simple Interesting Correlates or Kanker Markes

of Critical Predictive Nature?, Journal of Clinical Oncology, Volume 22,

Nuber 6, p: 975-77, www.jco.org

David, M.L. and Shivdasani, R., 2001, Toward Mechanism- Based Cancer Care,.

Research Opportunities For Spesific Diseases and Disorders,. JAMA..

Vol. 285. No. 5: pp. 588 – 93.

Davis, J. M., Novalonic, P. M., Weinstein-Oppenheimer, C. R., Steelman, L. S.,

Wei, H., Konopleva, M., Blagonskonny, M. V., and McCubrey, J. A.,

2003, Raf-1 and Bcl-2 Induce Distintc and Common Pathways That

Contribute to Breast Cancer Drug Resistence, Clinical Cancer Research,

Vol. 9, 1161-1170.

DepKes RI., 2000, Parameter Standar Umum Ekstrak Tumbuhan Obat, Cetakan

Pertama,Departemen Republik Indonesia, Jakarta, 11

Diananda, R., 2009, Mengenal Seluk Beluk Kanker, Katahati, Yogyakkarta

Dipiro., Joseph, T., Talbert., Robert, L., Gary, C., Yee, Gary R., Matzke, Barbara.

G. Wells., and L, M.P., Ed., 2005, Pharmacotherapy A Phatopysiologic

Approach Sixth Edition, USA, The McGraw-Hill Companies.

39

Doyle, A., and Griffith, J.B., 2000, Cell and Tissue Culture for Medical Research,

John Wiley and Sons, Ltd., New York.

Dyson, N., 1998, Genes & Development, The Regulation of E2F by pRB-family

Proteins, Cold Spring Harbor Laboratory Press, P: 2245-56,

http://www.genesdev.org/subscriptions/

Elwood, J., Cox B., and Richardson, A., 1993, The effectiveness of breast cancer

screening by mammography in younger women, Online J Curr Clin

Trials., 32

Fitri, R.K., 2014, Uji Aktivitas Antikanker Ekstrak Daun Sirsak (Annona

Muricata Linn.) Terhadap Beberapa Sel Kanker Manusia Secara In Vitro,

Skripsi, Universitas Airlangga, Surabaya.

Foster, J. S., Henley, D. C., Ahmed, S., and Wimalasena, J., 2001, Esterogen and

cell cycle Regulaton in Breast Cancer, Trend in Endocrinology and

Metabolism,12 (7) : 320-327

Fresney RI, 2005. Culture of Animal Cell: A Manual of Basic Technique. 5th Ed.

John Wiley and Sons. pp. 120-135.

Givan, A.L., 2001, Flowcytometry: First Priciples. Second Edition, Wiley-Liss,

Newyork.

Gewirtz, D.A., 1999, A critical evaluation of the mechanisms of action proposed

for the antitumor effects of the anthracycline antibiotics adriamycin and

daunorubicin, Biochem, Pharmacol, 57:727-741

Haijun, Y., Zhang, N., Zeng, Q., Yu, Q., Ke, S., and Li, X., 2010. HPLC Method

for Simultaneous Determination of Ten Annonaceous Acetogenins after

Supercritical Fluid CO2 Extraction. International Jurnal of Biomedical

Science 6:3, 202-7

Hanahan, D. and Weinberg, R.A., 2000, The hallmarks of cancer. Cell 100, 57-70

Harjolukito, E.S.R., 2004, Pemeriksaan Imunohistokimia sebagai Penentu

Prognosis dan Terapi pada Kanker Payudara, Bagian Patologi Anatomi

Fakultas Kedokteran Universitas Indonesia, Jakarta.

IARC, 2013, Latest World Cancer Statistics Global Cancer Burden Rises To 14.1

Million New Cases In 2012: Marked Increase In Breast Cancers Must Be

Addressed, World Health Organization

Kardinan, A, 2003, Tanaman Obat Pengempur Kanker, Agromedia Pustaka,

Depok.

Katzung, B.G., 1997, Farmakologi Dasar dan Klinik : Prinsip Kerja Obat

Antimikroba, Jakarta : Penerbit Buku Kedokteran EGC. pp. 699.

Khambri, Daan., 2015, Peran Terapi Hormonal Pada Kanker Payudara, 38, 1

Kim, Soong Geum. Lu Zeng. Lingling. Feng. Jerry L. Mc Laughlin. And

Soelaksono Sastrodihardjo, 1998, Two New Mono Tetrahydrofuran Ring

Acetogenins, Annomuricin E And Muricapentocin, From The Leaves Of

40

Annona muricata, American Chemical Society And American Society Of

Pharmacognosy.

King, R. J. B., 2000, Cancer Biology, 2nd

Edition, Pearson Education Ltd, London

King, M.W., 2004, Kanker Suppressors and Cancer, IU School of Medicine,

Sergio Marchesini, p:1-11. mailto:[email protected]

Lim, T.K., 2012. Annona muricata. In: Edible Medicine and Non Medicine, Vol. 1

Fruts, Lim, T.K. (Edt). Dondhrect Holdberg London New York: Springer

Science and Business Media BV, p. 190-200

Mangan, Y., 2003, Cara Bijak Menaklukkan Kanker, Jakarta: Agro Media

Pustaka, Halaman 2-23

Martini, S.D., dan Hestiningsih, R., 2005, Uji Sitotoksisitas Ekstrak Etanol

Momordica charantia L, Phyllantus niruri L., dan Andrographis

paniculata Ness Terhadap Sel HeLa, Mieloma, dan Sel B 958 Secara In

vitro, Laporan Kegiatan, Fakultas Kesehatan Masyarakat UNDIP,

Semarang.

MS, Prasetyo., dan Inoriah, S., 2013, Pengelolaan Budidaya Tanaman Obat-

Obatan (Bahan Simplisia), Fakultas Pertanian UNIB, Bengkulu,17-20

Nassar, Z. and Abdalrahim, A.M., 2010, The Pharmacological Properties of

terpenoid from Sandoricum Koetjape, Journal Medcentral, 2010, 1-11.

Rachma, F.A., 2012, Aktivitas Sitotoksik Ekstrak Etanol Kulit Batang Sirsak

(Annona Muricata L.) Terhadap Sel T47d Serta Profil Kromatografi

Lapis Tipis, Skripsi, Universitas Muhammadiyah Surakarta.

Radi, J., 1998, Sirsak Budidaya dan Pemanfaatannya, Bandung, Kanisius

Raintree, Nutrition., 2004, Monograph Graviola Annona Muricata, Carson city.

Rickwood, D., and Harris, J.R., 1996, Cell Biology, Essential Techniques, Jhon

Willey & Sons Ltd, Chichester, p: 38-66

Riono, Y., 1999, Kanker Leher Rahim, Dept. of Surgery Hollywood Hospital,

Australia.

Robinson, T., 1995, Kandungan Organik Tumbuhan Tinggi, diterjemahkan oleh

Kosasih Padmawinata, ITB, Bandung.

Rock, E., and DeMichele, A., 2003, Nutritional Approaches to Late Toxicities of

Adjuvant Chemotherapy in Breast Cancer Survivors, American Society

for Nutritional Sciences J Nutr,133: 3785-3793.

Santi, S.R., 2011, Senyawa Antimakan Triterpenoid Aldehid dalam Biji Sirsak

(Annona muricata Linn), Bukit Jimbaran: FMIPA Universitas Udayana,

Jurnal Kimia 5 (2), Juli 2011: 163-168.

Schafer, J.M., Lee, E.S., O’Regan, R.M., Yao, K., dan Jordan, V.C., 2000, Rapid

Development of Tamoxifen-stimulated Mutant p53 Breast

Septiatin, A., 2009, Apotik Hidup dari Rempah-Rempah dan Tanaman Liar,

CV.Yrama Widya: Bandung

41

Silalahi, J., 2006, Antioksidan dalam diet dan karsinogenesis, Cermin Dunia

Kedokteran 153:39:42

Soheil, Z.M., Mehran, F., Sonia, N., Gokula,, Mohan., Hapipah, M.Ali., Habsah,

A.K. Annona muricata (Annonaceae): A Review of Its Traditional Uses,

Isolated Acetogenins and Biological Activities. International Journal of

Molecular Sciences. 2015;16:15625-58.

Sunarjono, H., 2005, Sirsak dan Srikaya: Budi Daya Untuk Menghasilkan Buah

Prima. Penebar Swadaya : Jakarta.

Suryana, 2008, Kanker Payudara, Available from: http://studioshines.

wordpress.com/2017/05/01/kanker-payudara/

Taylor, Leslie., 2002, Technical Data Report For Graviola (Annona Muricata),

Preprinted From Herbal Secrets Of The Rainforest, 2nd Edition : Sage

Press

Taylor, L., 2012, Annona muricata. Herbal secret of the Rainforest: The Healing

Power of over 50 Medicinal Plants you Should Know About.

http://www.raintree.com/graviola.htm#.VOFqZixNfMw, diakses tanggal

20 Juni 2014.

Verma, S.P., Goldin, B.R., and Lin, P.S., 1998, The Inhibition of the Estrogenic

Effects of Pesticides dan Enviromental Chemicals by Curcumin and

Isoflavonoids, Envir. Health Presp, 106 (12), 807-812

Voight, R., 1994, Buku Pelajaran Teknologi Farmasi, diterjemahkan oleh Soedani

Noerono Soewandhi, Gadjah Mada University Press, Yogyakarta, 570-

571

Weerapreeyakul, N., Nonpunya, A., Barusrux, S., Thitimetharoch, T., and

Sripanidkulchai, 2012, Evaluation of The Anticancer Potential of Six

Herbs Against a Hepatoma Cell Line, Chinese Medicine, 7 (15), 1-7.

Xiaohe, Yang., Shihe, Yang., Christine, McKimmey.,Bolin, Liu., Susan, M.

Edgerton, W.B., Linda, T.A and Ann, D.T., 2010, Genestein induces

enhanced growth promotion in ER-positive/erbB-2 overexpressing breast

cancer by ER-erbB-2 cross talk and p27/kip I downregulation.

Carcinogenesis 31 : 695-702.

Yuan, S.S.F., Chang, H.L., Chen, H.W., Yeh, Y.T., Kao, Y.H., Lin, K.H., Wu,

Y.C., Su, J.H., 2003, Annonacin, a mono-tetrahydrofuran acetogenin,

arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and

caspase-3-related pathway, 72, 2853-2861.

Zou, T.B., En-Qin, Xia., Tai-Ping, He., Ming-Yuan, Huang., Qing, Jia., and Hua-

Wen, Li., 2014. Ultrasound-Assisted Extraction of Mangeferin from

Mango Leaves Using Response Surface Methodology. Molecules 19,

1411-1421.

42

Lampiran 1. Hasil Determinasi Tanaman Sirsak (Annona muricata L.)

43

Lampiran 1. Lanjutan

44

Lampiran 1. Lanjutan

45

Lampiran 2. Surat Keterangan telah Melaksanakan Penelitian di Laboratorium

Parasitologi Fakultas Kedokteran Universitas Gadjah Mada

Yogyakarta.

46

Lampiran 3. Perhitungan Sel T47D, Seri Konsentrasi Ekstrak Etanolik Biji

Sirsak

1. Sel T47D

a. Perhitungan Sel

Jumlah sel terhitung = 156 x 104

b. Pembuatan Suspensi Sel (Stok)

Sel T47D untuk perlakuan = 1 x 104 sel/sumuran

Jumlah sel yang ditanam dalam setiap sumuran adalah 10.000 sel

Volume yang diambil =

= 0,33 ml + Media Kultur (RPMI) ad 5

ml.

2. Seri Konsentrasi Ekstrak Etanolik Biji Sirsak

a. Pembuatan Larutan Stok Konsentrasi 100.000 µg

/ml

Sebanyak 11 mg Ekstrak Etanolik Biji Sirsak dilarutkan dalam 110 µl

DMSO ditambahkan media ad 10 ml.

Konsentrasi stok 10 mg/100 µl = 10.000 µg/100 µl = 100.000 µg/ml.

b. Pembuatan Seri Konsntrasi

Sel T47D 3 replikasi= 300 µl, dilebihkan menjadi 400 µl

Pembuatan seri konsentrasi 1000 µg

/ml

V1 X C1 = V2 X C2

V1 X 100.000 µg

/ml = 800 µl X 1000 µg

/ml

V1 =

= 8 µl ad 392 µl MK

47

(h)

MK

(a) (b) (c) (d) (e) (f) (g)

Keterangan konsentrasi: (a) 1000 ppm, 800 µl MK; (b) 500 ppm, 400 µl MK;

(c) 250 ppm, 400 µl MK; (d) 125 ppm, 400 µl MK; (e) 62,5 ppm, 400 µl MK; (f)

31, 25 ppm, 400 µl MK; (g) 15,625 ppm, 400 µl MK; (h) sampel EEBS 8 µl

48

Lampiran 4. Penentuan Nilai IC50 Ekstrak Etanolik Biji Sirsak pada Sel Kanker

Payudara T47D

Konsentrasi

EEBS (µg/ml)

Absorbansi

Rata-Rata

Absorbansi

%

Viabilitas

(%) 111 22 %sel

hidup33

500

125

62.5

31.25

15.625

0.143

0.709

0.707

0.744

0.792

0.143

0.749

0.84

0.732

0.834

0.15

0.706

0.73

0.783

0.788

0.145

0.721

0.759

0.753

0.805

2.76

83.50

88.79

87.94

95.19

Kontrol Media

Kontrol Sel

0.121

0.849

0.12

0.822

0.136

0.846

0.126

0.839

Perhitungan Nilai % Viabilitas EEBS

% Viabilitas =

% Viabilitas Kons 500 =

= 2,76 %

% Viabilitas Kons 125 =

= 83,50 %

% Viabilitas Kons 62,5 =

= 88,79 %

% Viabilitas Kons 31,25=

= 87,94 %

% Viabilitas Kons 15,625=

= 95,19 %

49

Lampiran 4. Lanjutan

Analisis Regresi Linier dengan Ms.Excel 2010

Y = -0,1903x + 99,593

R2

= 0,9837

Mencari IC50, sehingga Y = 50

50 = -1903x + 99,593

x =

= 260,604 µg/ml~261 µg/ml

Sehingga diperoleh IC50 Ekstrak Etanolik Biji Sirsak 261 µg/ml

y = -0.1903x + 99.593 R² = 0.9837

0

20

40

60

80

100

120

0 100 200 300 400 500 600

Konsentrasi EEBS (µg/ml)

Via

bil

itas

sel

(%

)

50

Lampiran 5. Perhitungan Sel dan Konsentrasi Ekstrak Etanolik Biji Sirsak

(EEBS) Uji Modulasi Siklus Sel

1. Sel T47D

a. Perhitungan Sel

Jumlah sel terhitung = 40x104

sel

b. Pembuatan Suspensi Sel (Stok)

Sel T47D untuk perlakuan = 10x105

sel/sumuran

Jumlah sel yang ditanam dalam setiap sumuran adalah 1.000.000 sel

Volume yang diambil= 2,5 ml

2. Perhitungan konsentrasi EEBS yang diambil

V1 X N1 = V2 X N2

5ml x 261 μg/ml = V2 X 100.000

V2 = 0,0130 ml

= 13 μl ad 5 ml Media Kultur (RPMI)

51

Lampiran 5. Lanjutan

(d)

2,5 RPMI

(a) (b) (c)

Keterangan konsentrasi: (a) 1 IC50 5ml RPMI+13 µl EEBS; (b) ½ IC50 2,5ml

RPMI; (c) ¼ IC50 2,5 ml RPMI; (d) EEBS 13 µl